Article

NeurologyLive® Friday 5 — July 28, 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 28, 2023.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Roundtable: Building a Greater Understanding for Dravet Syndrome

A duo of experts provide insight on various topics related to the advances in treatment options, diagnosis of the disorder, role of genetics, and potential future research and gene therapies.

Roundtable: Building a Greater Understanding for Dravet Syndrome

2: Peer Exchange: Concluding Thoughts on Biosimilars in Multiple Sclerosis

In episode 11 of the "How Similar are Biosimilars? A look into the Future with Biosimilars in Multiple Sclerosis" Peer Exchange series, Amy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.

Concluding Thoughts on Biosimilars in Multiple Sclerosis

3: NeuroVoices: Alessio Travaglia, PhD, on Utilizing Available Alzheimer Biomarkers Properly

In the latest edition of our in-depth Q&A series, the director at the Foundation for the National Institutes of Health provided perspective on the effective ways to utilize currently available biomarkers for Alzheimer disease research.

NeuroVoices: Alessio Travaglia, PhD, on Utilizing Available Alzheimer Biomarkers Properly

4: Neurology News Network: The Safety of Other S1P Receptor Modulators in Multiple Sclerosis

Krzysztof Selmaj, MD, PhD, presents the key results on the safety of other sphinogine-1-phospate (S1P) receptor modulators, such as fingolimod and ponesimod, in the treatment of multiple sclerosis (MS).

The Safety of Other S1P Receptor Modulators in Multiple Sclerosis

5: Advancing Research With Remote Blood Collection for Alzheimer Biomarkers: Hanna Huber, PhD

The researcher in the department of neurochemistry at the University of Gothenburg in Sweden discussed bloodspot cards as a promising method for collecting blood samples in Alzheimer disease research. [WATCH TIME: 4 minutes]

Advancing Research With Remote Blood Collection for Alzheimer Biomarkers: Hanna Huber, PhD

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Videos
Anna Pace, MD
Kristyn Pocock, MD
Dementia expert James Galvin, MD, MPH, a professor of neurology at the University of Miami Miller School of Medicine, and chief scientific officer at CogniVue
Rami Burstein, PhD
Michael Kaplitt, MD, PhD
2 experts are featured in this series.
2 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.